problendoПроблемы ЭндокринологииProblems of Endocrinology0375-96602308-1430Endocrinology Research Centre10.14341/probl201359234-39problendo-4641Research ArticleСтатьиArticlesПрименение теста с 5 мкг АКТГ в диагностике неклассической формы врожденной дисфункции коры надпочечников (итоги исследования)The application of the ACTH (5 mcg) test for diagnostics of the non-classical form of congenital adrenal hyperplasia (results of a study)ChagaĭN B-FadeevV V-Prokof'evS A-IvanovaO N-SmirnovaN B-AtamanovaT M-TishinaIu V-201315042013592ТОМ 59, №2 (2013)3439Copyright © Chagaĭ N.B., Fadeev V.V., Prokof'ev S.A., Ivanova O.N., Smirnova N.B., Atamanova T.M., Tishina I.V., 20132013Chagaĭ N.B., Fadeev V.V., Prokof'ev S.A., Ivanova O.N., Smirnova N.B., Atamanova T.M., Tishina I.V.Chagaĭ N.B., Fadeev V.V., Prokof'ev S.A., Ivanova O.N., Smirnova N.B., Atamanova T.M., Tishina I.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.probl-endojournals.ru/jour/article/view/4641

Показана высокая чувствительность и специфичность стимуляционного теста с 5 мкг 1-24-АКТГ в диагностике неклассической формы врожденной дисфункции коры надпочечников (дефицита 21-гидроксилазы).

This study has demonstrated high sensitivity and specificity of the low-dose (5 mcg) 1-24-ACTH stimulation test used for diagnostics of the non-classical form of congenital adrenal hyperplasia (21-hydroxilase deficiency).

неклассическая форма врожденной дисфункции коры надпочечниковнизкодозовый тестАКТГnon-classical form of congenital adrenal hyperplasialow-dose testACTHReferencesДедов И.И., Фадеев В.В., Мельниченко Г.А. Недостаточность надпочечников. М: Знание 2002; 203-218.Дедов И.И., Фадеев В.В., Мельниченко Г.А. Недостаточность надпочечников. М: Знание 2002; 203-218.Unlühizarci K., Keleєtimur F., Güven M., Bayram F., Colak R. The value of low dose (1 microg) ACTH stimulation test in the investigation of non-classic adrenal hyperplasia due to 11beta-hydroxylase deficiency. Exp Clin Endocrinol Diabet 2002; 110: 8: 381-385.Unlühizarci K., Keleєtimur F., Güven M., Bayram F., Colak R. The value of low dose (1 microg) ACTH stimulation test in the investigation of non-classic adrenal hyperplasia due to 11beta-hydroxylase deficiency. Exp Clin Endocrinol Diabet 2002; 110: 8: 381-385.Panamonta O., Thinkhamrop B., Kirdpon W., Pudtawaro L.O., Sungsahachart D. Adrenocorticotropin stimulation test in congenital adrenal hyperplasia: comparison between standard and low dose test. J Med Ass Thai 2003; 86: 7: 634-640.Panamonta O., Thinkhamrop B., Kirdpon W., Pudtawaro L.O., Sungsahachart D. Adrenocorticotropin stimulation test in congenital adrenal hyperplasia: comparison between standard and low dose test. J Med Ass Thai 2003; 86: 7: 634-640.Чагай Н.Б., Фадеев В.В., Бакулина Е.Г. Низкодозированный тест с АКТГ в диагностике неклассической формы врожденной дисфункции коры надпочечников. Пробл эндокринол 2010; 2: 10-14.Чагай Н.Б., Фадеев В.В., Бакулина Е.Г. Низкодозированный тест с АКТГ в диагностике неклассической формы врожденной дисфункции коры надпочечников. Пробл эндокринол 2010; 2: 10-14.http://www.issam.ch/freetesto.htmhttp://www.issam.ch/freetesto.htmLee H., Chang J., Tsai C., Tsai F., Chao H., Chung B. Analysis of the chimeric CYP21 P/CYP 21 gene in steroid 21-hydroxylase deficiency. Clin Chem 2000; 46: 5: 606-611.Lee H., Chang J., Tsai C., Tsai F., Chao H., Chung B. Analysis of the chimeric CYP21 P/CYP 21 gene in steroid 21-hydroxylase deficiency. Clin Chem 2000; 46: 5: 606-611.Wedell A., Luthman H. Steroid 21-hydroxylase deficiency: two additional mutations in salt-wasting disease and rapid screening of disease-causing mutations. Human Mol Genet 1993; 2: 5: 499-504.Wedell A., Luthman H. Steroid 21-hydroxylase deficiency: two additional mutations in salt-wasting disease and rapid screening of disease-causing mutations. Human Mol Genet 1993; 2: 5: 499-504.New M.I. Nonclassical 21-Hydroxylase Deficiency. J Clin Endocrinol Metabol 2006; 91: 11: 4205-4214.New M.I. Nonclassical 21-Hydroxylase Deficiency. J Clin Endocrinol Metabol 2006; 91: 11: 4205-4214.Moran C. Nonclassic adrenal hyperplasia. Fertil Steril 2006; 86: Suppl 1: S3.Moran C. Nonclassic adrenal hyperplasia. Fertil Steril 2006; 86: Suppl 1: S3.Schindhelm R.K., van de Leur J.J., Rondeel J.M. Salivary cortisol as an alternative for serum cortisol in the low-dose adrenocorticotropic hormone stimulation test? J Endocrinol Invest 2010; 33: 2: 92-95.Schindhelm R.K., van de Leur J.J., Rondeel J.M. Salivary cortisol as an alternative for serum cortisol in the low-dose adrenocorticotropic hormone stimulation test? J Endocrinol Invest 2010; 33: 2: 92-95.Simůnková K., Hampl R., Hill M., Doucha J., Stárka L., Vondra K. Salivary cortisol in low dose (1 microg) ACTH test in healthy women: comparison with serum cortisol. Physiol Res 2007; 56: 4: 449-453.Simůnková K., Hampl R., Hill M., Doucha J., Stárka L., Vondra K. Salivary cortisol in low dose (1 microg) ACTH test in healthy women: comparison with serum cortisol. Physiol Res 2007; 56: 4: 449-453.White P.C., Speiser P.W. Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency. Endocrin Rew 2000; 21: 3: 245-291.White P.C., Speiser P.W. Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency. Endocrin Rew 2000; 21: 3: 245-291.L'Allemand D., Tardy V., Grüters A., Schnabel D., Krude H., Morel Y. How a patient homozygous for a 30-kb deletion of the C4-CYP 21 genomic region can have a nonclassic form of 21-hydroxylase deficiency. J Clin Endocrinol Metabol 2000; 85: 12: 4562-4567.L'Allemand D., Tardy V., Grüters A., Schnabel D., Krude H., Morel Y. How a patient homozygous for a 30-kb deletion of the C4-CYP 21 genomic region can have a nonclassic form of 21-hydroxylase deficiency. J Clin Endocrinol Metabol 2000; 85: 12: 4562-4567.Wedell A., Luthman H. Steroid 21-hydroxylase deficiency: two additional mutations in salt-wasting disease and rapid screening of disease-causing mutations. Hum Mol Genet 1993; 2: 5: 499-504.Wedell A., Luthman H. Steroid 21-hydroxylase deficiency: two additional mutations in salt-wasting disease and rapid screening of disease-causing mutations. Hum Mol Genet 1993; 2: 5: 499-504.

The authors declare that there are no conflicts of interest present.